by Sean Hutchinson | Feb 20, 2023 | EPO, UPC
We reported in our article of December 2022 that the start date of the Unified Patent Court (“UPC”) had been delayed yet again, this time in view of some difficulties many users were having with acquiring the authentication devices required to access the UPC’s Case...
by Eddie Bishop | Feb 3, 2023 | EPO
Background Historically (pre-2019), a subrange was considered novel over the prior art if the following criteria were met (T198/84 and T279/89): a) The selected subrange is narrower than the known range; b) The selected subrange is sufficiently far removed from any...
by Vicky Colley | Jan 13, 2023 | News
Schlich has in particular been noticed for our work on patent filings for some of our well known clients such as AbbVie, Dimension Genomics, Fred Hutchinson Cancer Center, ONK Therapeutics, Vector Vitale, as well as a number of US universities. Our litigation work in...
by Carolyn Haywood | Jan 11, 2023 | EPO
Timeline of events The applicant filed a Petition for Review against the ‘decision’ of the Board of Appeal in T 0695/18 of 5 October 2021 not to consider their submissions of 29 September and 5 October 2021 respectively. The Petition for Review was based on (i)...
Recent Comments